Sat. Jul 20th, 2024

Piramal’s D2C Platform, Wellify adopts Unicommerce to streamline its Ecommerce Operations07th February 2024, New Delhi: Piramal’s health & wellness D2C platform, Wellify has joined hands with  Unicommerce, one of India’s leading e-commerce enablement SaaS platforms, to streamline its supply chain and elevate the post-purchase experience for its end consumers. The company will be managing orders and warehouse operations for Little’s, Lacto-calamine, Tri-activ, I-feel, Ourdaily and Sloan’s through the Unicommerce platform.

Wellify has deployed Unicommerce’s order management and warehouse management solutions to enhance warehouse operations and accelerate order processing. With the growing popularity of Wellify’s products in the Indian market, the brand has been witnessing high order volumes. To smoothen operational challenges such as unsynchronized inventory, return order management, order allocation, bulk order management, and logistics management, the company has collaborated with Unicommerce. This partnership enables Wellify to integrate all its warehouses onto a single platform, which allows it to allocate orders to the nearest warehouse automatically and streamlines order management processes.

The Unicommerce platform has also provided a batching facility for products that have an expiration period. It allows the brand to automatically allocate products from the batch with the most recent expiration date and shields such crucial deliveries by making the order process error-free. Additionally, the platform’s centralized window offers complete visibility of orders and inventory, simplifying its operations across multiple warehouses.

Wellify is an initiative of Piramal’s consumer products division, which is among the leading players in the self-care space in India and is one of the flagship businesses of the Piramal Group. The new-age brand offers a wide variety of products ranging from categories like baby care, skin care, hygiene & protection, pain management and wellness among others. The D2C brand currently manages four warehouses across Mumbai, Bangalore, Kolkata and Ambala and processes 80000 – 85000 orders in a month.

Kapil Makhija, CEO of Unicommerce, commented, “We are proud to join hands with Wellify in deploying an effective supply chain system that helps automate supply chain processes and enhances capabilities to handle the rising number of orders. Unicommerce has strategically established a strong foothold in the Indian market, with a track record of success across diverse industry sectors. Our scalable and robust product architecture gives us an edge and makes us a preferred choice of companies looking to accelerate their business growth.”

On the partnership Nitish Bajaj, CEO, Piramal (Consumer Pharma Division) said, “Our primary objective is to provide an excellent customer experience while strengthening our position in the eHealth sector. Unicommerce stands out as one of the top-notch integrated supply chain technology platforms for e-commerce enterprises in India, and we are delighted to have them as our partners. We are confident that technology will be a crucial factor in delivering a smooth shopping experience to our customers, and this collaboration represents a significant step in that direction.”

Unicommerce is India’s largest e-commerce enablement SaaS platform in the transaction processing layer, in terms of revenue for the financial year concluded March 2022. The company’s suite of SaaS solutions enables end-to-end management of e-commerce operations for brands, retailers, marketplaces and logistics service providers. The company has a consistently growing Annual Recurring Revenue (ARR)and Revenue. As of the quarter ending September 2023, Unicommerce has achieved a 750 million+ Annual Transaction run-rate, serving over 3500 customers, managing 8000+ warehouses, and processing orders from 1900+ stores through its platform.

“Unicommerce eSolutions Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, to make an initial public offer of its equity shares and has filed a draft red herring prospectus (“DRHP”) with the Securities and Exchange Board of India. The DRHP is available on the websites of the Company at, SEBI at as well as on the website of the book running lead managers, IIFL Securities Limited and CLSA India Private Limited at and, respectively. Investors should note that investment in equity shares involves a high degree of risk. For details, potential investors should refer to the DRHP, including the section titled “Risk Factors”.

Leave a Reply

Your email address will not be published. Required fields are marked *